Current concepts in the diagnosis and management of antiphospholipid syndrome and ocular manifestations

• Published in: Journal of ophthalmic inflammation and infection Vol. 11; no. 1; p. 11
• Main Authors: Uludag, Gunay, Onghanseng, Neil, Tran, Anh N. T., Hassan, Muhammad, Halim, Muhammad Sohail, Sepah, Yasir J., Do, Diana V., Nguyen, Quan Dong
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 09-04-2021; Springer Nature B.V; SpringerOpen
• Subjects: Antiphospholipid antibodies; Antiphospholipid syndrome; Autoimmune diseases; Medical diagnosis; Medicine; Medicine & Public Health; Ocular manifestations; Ophthalmology; Pathogenesis; Review; Antiphospholipid antibodies; Ocular manifestations; Antiphospholipid syndrome
• ISSN: 1869-5760; 1869-5760
• DOI: 10.1186/s12348-021-00240-8

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with obstetrical complications, thrombotic complications involving both arteries and veins, and non-thrombotic manifestations affecting multiple other systems presenting in various clinical forms. Diagnosis requires the presence of antiphospholipid antibodies. The exact pathogenesis of APS is not fully known. However, it has recently been shown that activation of different types of cells by antiphospholipid antibodies plays an important role in thrombosis formation. Ocular involvement is one of the important clinical manifestations of APS and can vary in presentations. Therefore, as an ophthalmologist, it is crucial to be familiar with the ocular findings of APS to prevent further complications that can develop. Furthermore, the ongoing identification of new and specific factors contributing to the pathogenesis of APS may provide new therapeutic options in the management of the disease in the future.